Article info
Chronic obstructive pulmonary disease
Original research
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD
- Correspondence to Dr Susan Muiser, Department of Pulmonology, University Medical Centre Groningen, Groningen 9713, The Netherlands; s.muiser{at}umcg.nl
Citation
Budesonide/formoterol maintenance and reliever therapy versus fluticasone/salmeterol fixed-dose treatment in patients with COPD
Publication history
- Received October 7, 2022
- Accepted December 19, 2022
- First published February 1, 2023.
Online issue publication
April 13, 2023
Article Versions
- Previous version (1 February 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.